CING
Cingulate Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.10
−2.30%Leverage
- Debt / equity
- 0.27x
- Net debt / equity
- -0.94x
- Debt / assets
- 0.19x
- Debt / EBITDA
- 0.03x
- Net debt / EBITDA
- -0.11x
Liquidity & coverage
- Current ratio
- 3.50x
- Quick ratio
- 3.50x
- Cash ratio
- 3.29x
- Interest coverage
- -20.43x
- EBITDA / interest
- 159.40x
- Working capital
- $21.6M
Cash & dividend
- FCF / debt
- -3.33x
- Cash flow / debt
- -3.28x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026